Analyst Ratings for Akari Therapeutics (AKTX)
AKTX Rating Summary
AKTX Price Target Summary
- Highest: $30.00 (Maxim Group)
- Lowest: $1.00 (Ladenburg Thalmann)
- Average: $10.87
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.87 (+4.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$10.87 (+4.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | Maxim Group | Jason McCarthy | Upgrade | Buy (Hold) |
30.00 (N/A) |
11.01 (10.37) |
-5.81% | Details |
| 1/5/2026 | Ladenburg Thalmann | Aydi | New Coverage | Buy (N/A) |
1.00 (N/A) |
0.29 (10.37) |
3475.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
